VAQTA 50 [iU]/mL

VAQTA 50 [iU]/mL is an inactivated hepatitis A vaccine designed to prevent hepatitis A virus infection. This intramuscular injection is suitable for individuals seeking protection against hepatitis A.

VAQTA 50 [iU]/mL is used to prevent hepatitis A, a viral liver disease. This vaccine is typically administered to individuals who are at risk of exposure to the hepatitis A virus, such as travelers to regions with high rates of hepatitis A or those in close contact with infected persons. The vaccine works by stimulating the body's immune response to develop protection against the virus.

Common effects of VAQTA 50 [iU]/mL may include soreness, redness, or swelling at the injection site. Some individuals may experience mild fever, headache, or fatigue following vaccination. These effects are usually temporary and resolve on their own.

VAQTA 50 [iU]/mL should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform the healthcare provider about any current medications or health conditions before receiving the vaccine.

VAQTA 50 [iU]/mL may interact with certain medications or other vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving this vaccine. Alcohol and other immune-suppressing substances may affect the vaccine's effectiveness.